Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Hepatopulmonary Syndrome

ClinicalTrials.gov lists 15 trials for Hepatopulmonary Syndrome or a narrower condition beneath it.

MeSH D020065 Digestive System Diseases C06 C08
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 2 Phase 2 Phase 2 4 Not applicable Not applicable 3 Observational Observational 6 Phase 1 Phase 1 2 Phase 2 Phase 2 4 Not applicable Not applicable 3 Observational Observational 6

Trials per phase

15 of the 15 trials are tagged with Hepatopulmonary Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Hepatopulmonary Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Hepatopulmonary Syndrome trials start? (12)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Not applicable
  • Observational

Top of scale: 2

2004: 1 trials (Phase 1 1) 2006: 2 trials (Observational 1, Phase 2 1) 2011: 1 trials (Phase 2 1) 2012: 1 trials (Not applicable 1) 2014: 2 trials (Observational 1, Phase 2 1) 2015: 1 trials (Observational 1) 2017: 1 trials (Observational 1) 2018: 2 trials (Observational 1, Phase 1 1) 2019: 1 trials (Not applicable 1) 2021: 1 trials (Phase 2 1) 2022: 1 trials (Not applicable 1) 2023: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2023 1
2022 1
2021 1
2019 1
2018 2
2017 1
2015 1
2014 2
2012 1
2011 1

No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Hepatopulmonary Syndrome trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 2
Phase 2 4
Not applicable 3
Observational 6

How many Hepatopulmonary Syndrome trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Enrolling by invitation 1
Completed 3
Terminated 4
Unknown status 7

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Hepatopulmonary Syndrome? (4)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Pentoxifylline 2
Sorafenib 1
Norfloxacin 1
BOSENTAN 1

Interventions as named in the registry (4)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Midodrine 2.5 mg tab 1
Letrozol (Femara, Novartis) 1
pentoxifylline and rifaximin 1
Proteomic sequencing 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Hepatopulmonary Syndrome trials report? (8)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Liver transplant 3 1
Basal cell carcinoma 2 1
Encephalopathy 2 1
Diagnostic procedure 1 1
Hypoxia 1 1

Which publications cover Hepatopulmonary Syndrome? (13)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial. Trials 2021 Yes
Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017 Yes
Inflammatory bowel diseases, chronic liver diseases and the lung. The European respiratory journal 2016 Yes
Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010 Yes
Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages